Is TCRX or TLSA more undervalued in 2026?

CirclFi compares TScan Therapeutics, Inc. (TCRX) and Tiziana Life Sciences Ltd (TLSA) using 13 institutional-grade valuation models. TCRX has a Quality of Company score of 6.4/10 while TLSA scores 1.7/10.

Which is a better buy — TCRX or TLSA?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do TCRX and TLSA valuations compare?

TCRX at $1.08 and TLSA at $1.46 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

TCRX vs TLSA Valuation Comparison 2026 — Intrinsic Value Analysis

TCRX

Biotechnology

TScan Therapeutics, Inc.

Quality

6.4

out of 10

Value Trap

SAFE

Price

$1.08

Last close

Models

9/13

Active

TLSA

Biotechnology

Tiziana Life Sciences Ltd

Quality

1.7

out of 10

Value Trap

—

Price

$1.46

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	TCRX Fair Value	TCRX Upside	TLSA Fair Value	TLSA Upside
Bayesian DCF	Intrinsic	$0.71	-34.5%	$0.39	-73.5%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$1.66	+53.8%	$1.11	-24.3%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$1.67	+54.2%	$1.41	-3.8%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for TCRX vs TLSA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

TCRX vs TLSA — Which Stock Is More Undervalued?

TCRX scores higher with a 6.4/10 quality rating vs TLSA's 1.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing TScan Therapeutics, Inc. (TCRX) and Tiziana Life Sciences Ltd (TLSA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

TCRX currently trades at $1.08 with a QOC of 6.4/10, while TLSA trades at $1.46 with a QOC of 1.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).